NEOPLASMS, GLANDULAR AND EPITHELIAL
Clinical trials for NEOPLASMS, GLANDULAR AND EPITHELIAL explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, GLANDULAR AND EPITHELIAL trials appear
Sign up with your email to follow new studies for NEOPLASMS, GLANDULAR AND EPITHELIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug could slash surgeries for rare airway disease
Disease control OngoingThis phase II trial tests whether bevacizumab, a drug that blocks blood vessel growth, can lengthen the time between surgeries for adults with recurrent respiratory papillomatosis (RRP), a rare condition causing wart-like growths in the airways. Participants receive 11 doses of t…
Matched conditions: NEOPLASMS, GLANDULAR AND EPITHELIAL
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a targeted pill slow brain tumor growth after surgery?
Disease control APPROVED_FOR_MARKETINGThis expanded access program offers vorasidenib, an oral drug, to people aged 12 and older with IDH-mutated glioma who have had surgery. The drug targets specific genetic mutations in tumor cells. The goal is to see if it can help control the disease without immediate need for ra…
Matched conditions: NEOPLASMS, GLANDULAR AND EPITHELIAL
Sponsor: Servier • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Robotic surgery or radiation? new study compares which is better for throat cancer patients' quality of life
Symptom relief OngoingThis study compares two treatments for early-stage throat cancer: robotic surgery (TORS) or radiation therapy (IMRT). It looks at which one leads to better swallowing function and overall quality of life. About 138 adults with HPV-related throat cancer are taking part. The goal i…
Matched conditions: NEOPLASMS, GLANDULAR AND EPITHELIAL
Phase: NA • Sponsor: Christian von Buchwald • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC